Waning protection of influenza vaccine against mild laboratory confirmed influenza A(H3N2) and B in Spain, season 2014–15
Alin Gherasim(Instituto de Salud Carlos III), Amparo Larrauri(Instituto de Salud Carlos III), Inma Aspiritxaga Gamarra(Departamento de Salud), Francisco Pozo(Instituto de Salud Carlos III), Jaume Giménez Durán, Eva Martínez(Universitat Autònoma de Barcelona), Salvador de Mateo(Instituto de Salud Carlos III), Manuel Garcìa Cenoz(Instituto de Salud Pública de Navarra), Tomás Vega, Daniel Castrillejo(Consejería de Educación de la Junta de Castilla y León)
Cited by 26
Related Papers
First cases of coronavirus disease 2019 (COVID-19) in the WHO European Region, 24 January to 21 February 2020
|Eurosurveillance|2020|715
Estimates of Pandemic Influenza Vaccine Effectiveness in Europe, 2009–2010: Results of Influenza Monitoring Vaccine Effectiveness in Europe (I-MOVE) Multicentre Case-Control Study
|PLoS Medicine|2011|303
Excess all-cause mortality during the COVID-19 pandemic in Europe – preliminary pooled estimates from the EuroMOMO network, March to April 2020
|Eurosurveillance|2020|238